SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Cashflow Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-0.89 Cr | ₹-3.38 Cr | ₹4.74 Cr | ₹-0.64 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-0.89 Cr |
| Mar2025 | ₹-3.38 Cr |
| Mar2024 | ₹4.74 Cr |
| Mar2023 | ₹-0.64 Cr |
How is Net Cash Inflow / Outflow of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-0.89 Cr | Negative | |
| Mar2025 | ₹-3.38 Cr | Negative | |
| Mar2024 | ₹4.74 Cr | Positive | |
| Mar2023 | ₹-0.64 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,765.8 Cr | -3.7% | -12.2% | 36.5% | Stock Analytics | |
| PRIME FOCUS | ₹22,568.7 Cr | 0.5% | 25% | 91.4% | Stock Analytics | |
| SAGILITY | ₹21,529.4 Cr | 13.7% | 16.1% | -0% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,100.3 Cr | -1.9% | -7.6% | -39.1% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,931.1 Cr | 2% | -3.5% | -14.3% | Stock Analytics | |
| INDEGENE | ₹12,394.4 Cr | 4.4% | 0.2% | -6.3% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -3.7% |
-12.2% |
36.5% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses